Clinical Neuromuscular Pathology Certification Examination Committee Contributors
P. James B. Dyck, MD, FAAN, Chair, Mayo Clinic
Disclosures: Receives fees from Akcea pharmaceutical for speaking about TTR amyloid neuropathy.
Robert C. Bucelli, MD, PhD, Washington University School of Medicine
Disclosures: Receives research support from Biogen for multiple ALS ASO trials at Washington University. Role: Principal investigator.
Andrea M. Corse, MD, Johns Hopkins University School of Medicine
Disclosures: Received research funding from Biogen to present A Phase I, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 Administered Intrathecally to Adults with C9ORF72-Associated Amyotrophic Lateral Sclerosis.
Praful Kelkar, MD, FAANEM, Minneapolis Clinic of Neurology
Disclosures: Receives speaker honoraria from Teva and Sanofi Genzyme.
Justin Yuan-Ping Kwan, MD, Temple University
Disclosures: Nothing to disclose.
Steven Lovitt, MD, The Neurology Center
Disclosures: Receives speaker fees from Alexion Pharmaceuticals.
Michelle L. Mauermann, MD, Mayo Clinic
Disclosures: Receives research support from Alnylam for TTR amyloid clinical trial and from IONIS for TTR amyloid clinical trial.
Margherita Milone, MD, PhD, Mayo Clinic
Disclosures: Receives compensation for serving as associate editor of Neurology Genetics; Receives research funding by Mayo Clinic benefactor.
Aziz Shaibani, MD, FACP, FAAN, Baylor College of Medicine
Disclosures: Received compensation to serve on Stealth BioTherapeutics advisory board regarding primary mitochondrial myopathy (PMM) and elamipretide.